Article

Top 10 Most Read Articles on Pharmacy Times from 2017

A look at some of the top read articles on Pharmacy Times from 2017.

From informative insights to newsworthy industry coverage, there were several articles that stood out from the rest this past year.

These were some of the most read articles on Pharmacy Times from 2017:

10. Acetaminophen and Warfarin: The Forgotten Interaction

Up to 18% of patients taking warfarin also take acetaminophen, but clinicians may not recognize the potential interaction between the 2 medications. Read more about the potential interactions, mechanisms, and recommendations for managing patients taking both drugs.

9. New Jersey Enacts Strict Opioid Prescribing Law

In February 2017, Governor Chris Christie of New Jersey signed new legislation aimed at curbing the state’s opioid epidemic. Read more here.

8. Want to Work for Amazon? You May Get the Chance Soon

How will Amazon change the pharmacy landscape? This article offers insight into what might happen for pharmacists with Amazon as a potential player in the pharmacy space. Read more here.

7. Study Hacks: How to Memorize Drug Side Effects​​​​​​​

There’s a lot of drug information you must memorize before you graduate and become a pharmacist. This article offers several useful techniques on how to learn the many drug side effects. Read more here.

6. Why the Drop in the NAPLEX Pass Rates?​​​​​​​

In 2016, the lowest overall pass rate for the North American Pharmacist Licensure Examination (NAPLEX) was seen, dropping to 85% overall. This article discusses what may have accounted for the lower pass rate. Read more here.

Read here to find out which pharmacy schools stood out as top NAPLEX performers.

5. Which Antibiotics Are Most Associated with Causing Clostridium difficile Diarrhea?

Are certain antibiotics more associated with increased risk of C difficile infection than others? This article weighs the risks of different antibiotic classes. Read more here.

4. Xyzal Now Approved for OTC Use

Sanofi’s 24-hour formulation of levocetirizine dihydrochloride (Xyzal Allergy 24HR) made news this year when it received FDA approval for OTC treatment of symptoms associated with seasonal and year-round allergies. Read more here.

3. Should the Schedule Change on Gabapentin?​​​​​​​

Gabapentin is not scheduled as a controlled substance, but the drug does show characteristics of medications associated with misuse and addiction. This article delves into whether or not gabapentin should have a schedule change. What do you think? Read more here.

2. The Top 200 Drugs of 2017?

The top 200 drugs, calculated and listed on ClinicCalc.com, can be difficult to memorize in the order they appear. This article provides tips on how to learn the drug list. Read more here.

1. 5 Things You Should Not Say at the Pharmacy

There are some things that should not be said at the pharmacy. This article presents a list of some of the most cringe-worthy things customers have said. Read more here.

Related Videos